These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 12080056
21. Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate. Sazonova IY, Thomas BM, Gladysheva IP, Houng AK, Reed GL. J Thromb Haemost; 2007 Oct; 5(10):2087-94. PubMed ID: 17883703 [Abstract] [Full Text] [Related]
29. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding. Jiao J, Yu M, Ru B. Biochim Biophys Acta; 2001 Apr 07; 1546(2):399-405. PubMed ID: 11295444 [Abstract] [Full Text] [Related]
30. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice. Okada K, Ueshima S, Tanaka M, Fukao H, Matsuo O. Blood Coagul Fibrinolysis; 2000 Oct 07; 11(7):645-55. PubMed ID: 11085285 [Abstract] [Full Text] [Related]
31. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors. Komorowicz E, Kolev K, Machovich R. Biochemistry; 1998 Jun 23; 37(25):9112-8. PubMed ID: 9636057 [Abstract] [Full Text] [Related]
32. Identification of a new exosite involved in catalytic turnover by the streptokinase-plasmin activator complex during human plasminogen activation. Aneja R, Datt M, Singh B, Kumar S, Sahni G. J Biol Chem; 2009 Nov 20; 284(47):32642-50. PubMed ID: 19801674 [Abstract] [Full Text] [Related]
33. Regulation of nonproteolytic active site formation in plasminogen. Gladysheva IP, Sazonova IY, Houng A, Hedstrom L, Reed GL. Biochemistry; 2007 Jul 31; 46(30):8879-87. PubMed ID: 17616171 [Abstract] [Full Text] [Related]
34. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Parry MA, Zhang XC, Bode I. Trends Biochem Sci; 2000 Feb 31; 25(2):53-9. PubMed ID: 10664583 [Abstract] [Full Text] [Related]
36. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation. Henderson SJ, Stafford AR, Leslie BA, Kim PY, Vaezzadeh N, Ni R, Fredenburgh JC, Weitz JI. Thromb Haemost; 2015 Jun 31; 113(6):1278-88. PubMed ID: 25789495 [Abstract] [Full Text] [Related]
37. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase. Holvoet P, Laroche Y, Lijnen HR, Van Hoef B, Brouwers E, De Cock F, Lauwereys M, Gansemans Y, Collen D. Eur J Biochem; 1992 Dec 15; 210(3):945-52. PubMed ID: 1483477 [Abstract] [Full Text] [Related]
38. [Catalytic properties of plasmin and the equimolar plasmin-streptokinase complex in their reactions with various substrates and inhibitors]. Aĭsina RB, Zhitkova IuV, Fedorenko IaE, Kazanskaia NF. Ukr Biokhim Zh (1978); 1991 Dec 15; 63(1):13-20. PubMed ID: 1827550 [Abstract] [Full Text] [Related]
40. Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the alpha 3 subunit of laminin-5. Goldfinger LE, Jiang L, Hopkinson SB, Stack MS, Jones JC. J Biol Chem; 2000 Nov 10; 275(45):34887-93. PubMed ID: 10956663 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]